Jon R. Iredell
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Phage therapy: from basic biology to clinical application.
Journal: Nature reviews. Microbiology
Published: July 22, 2026
Australian Group on Antimicrobial Resistance (AGAR) surveillance outcome programs - bloodstream infections and antimicrobial resistance patterns in Australian children and adolescents, January 2022 - December 2023.
Journal: Communicable diseases intelligence (2018)
Published: November 17, 2025
Multidrug-resistant organism carriage in Vietnamese district hospitals before and after an antimicrobial stewardship intervention.
Journal: Antimicrobial resistance and infection control
Published: September 16, 2025
Reprogramming resistance: phage-antibiotic synergy targets efflux systems in ESKAPEE pathogens.
Journal: mBio
Published: September 08, 2025
Australian Group on Antimicrobial Resistance surveillance outcome programs - bloodstream infections and antimicrobial resistance patterns from patients less than 18 years of age, January 2020 - December 2021.
Journal: Communicable diseases intelligence (2018)
Published: August 21, 2024
Personalized bacteriophage therapy for difficult-to-treat infections.
Journal: Nature microbiology
Published: June 04, 2024
Antimicrobial Resistance in Staphylococcus aureus and Enterococcus spp. Isolates From Bloodstream Infections in Australian Children, 2013-2021.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: April 29, 2024
Antimicrobial Resistance in Enterobacterales, Acinetobacter spp. and Pseudomonas aeruginosa Isolates From Bloodstream Infections in Australian Children, 2013-2021.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: April 29, 2024
Phage Therapy in Korea: A Prescribers' Survey of Attitudes Amongst Korean Infectious Diseases Specialists Towards Phage Therapy.
Journal: Infection & chemotherapy
Published: July 10, 2023
IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study.
IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study.
Journal: Frontiers in immunology
Published: October 03, 2022
Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients.
Journal: Scientific reports
Published: January 05, 2021
Last Updated: 09/26/2026